JPRN-UMIN000027208招募中未知
A pilot study for the effect of infliximab on endothelial function in patients with psoriasis - The effect of infliximab on endothelial function in patients with psoriasis
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who are treated with other biologics within 3 months 2. Patients treated with cyclosporine within 2 weeks 3. Patients with the past history of severe hypersensitivity or anaphylaxis against infliximab or drugs including murine proteins. 4. Patients with or suspected of having malignancy 5. Patients with serious infection, such as sepsis and positivity of Hepatitis B virus antigen 6. Patients with active or the past history of tuberculosis 7. Patients with active or the past history of demyelinating diseases 8. Patients with congestive heart failure 9. Patients with serious liver diseases (more than 300 IU of AST or ALT) 10. Patients with serious kidney diseases (serum creatinine >= 2.0mg/dl) 11. Patients under or suspected of pregnancy 12. Patients under breast feeding 13. Patients who are regarded to be inappropriate for this study by doctors
研究者
相似试验
已完成
不适用
Prospective Pilot study of Infliximab Dose-intensification determined by Capsule Endoscopic Evaluation of Small Intestinal Involvements in Patients with Crohn's Diseases diseaseCrohn's diseaseJPRN-UMIN000012790Saitama Medical center20
进行中（未招募）
1 期
BackToBasic: The effect of Infliximab in patients with chronic low back pain and vertebral oedema on MRI scan.A randomized, double blind, placebo-controlled, multicenter trialon-specific chronic low back pain of more than 6 months duration. We will only investigate those who have vertebral end-plate chanages(Modic changes) on MRI.MedDRA version: 20.0Level: LLTClassification code 10008837Term: Chronic back painSystem Organ Class: 100000004859EUCTR2017-004861-29-NOFOU, Nevroklinikken, Oslo University Hospital -Ullevål126
已完成
3 期
A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's DiseaseBehcet DiseaseNCT02505568Janssen Korea, Ltd., Korea33
已完成
不适用
"Effect examination of infliximab to the effect insufficient example and the example of effect decrease of the 1st TNF inhibitor in rheumatoid arthritis "Rheumatoid ArthritisJPRN-UMIN000007786Saitama Medical Center. Saitama Medical University40
已完成
3 期
Efficacy of Infliximab comparing with Cyclophosphamide in refractory uveitis in Behcet’s diseasesBehcet's diseaseIRCT20180110038297N1Zanjan University of Medical Sciences20